269 related articles for article (PubMed ID: 25686837)
1. CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Zheng X; Song T; Dou C; Jia Y; Liu Q
Oncotarget; 2015 Feb; 6(6):3752-69. PubMed ID: 25686837
[TBL] [Abstract][Full Text] [Related]
2. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Du R; Wu S; Lv X; Fang H; Wu S; Kang J
J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 is up-regulated by GLI1 and contributes to GLI1-driven EMT in hepatocellular carcinoma.
Gai X; Lu Z; Tu K; Liang Z; Zheng X
PLoS One; 2014; 9(1):e84551. PubMed ID: 24454730
[TBL] [Abstract][Full Text] [Related]
6. Metastasin leads to poor prognosis of hepatocellular carcinoma through partly inducing EMT.
Zheng X; Gai X; Wu Z; Liu Q; Yao Y
Oncol Rep; 2013 May; 29(5):1811-8. PubMed ID: 23483190
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor GLI1 mediates TGFβ1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanism.
Zheng X; Vittar NB; Gai X; Fernandez-Barrena MG; Moser CD; Hu C; Almada LL; McCleary-Wheeler AL; Elsawa SF; Vrabel AM; Shire AM; Comba A; Thorgeirsson SS; Kim Y; Liu Q; Fernandez-Zapico ME; Roberts LR
PLoS One; 2012; 7(11):e49581. PubMed ID: 23185371
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling.
Liu Z; Tu K; Wang Y; Yao B; Li Q; Wang L; Dou C; Liu Q; Zheng X
Cell Physiol Biochem; 2017; 44(5):1856-1868. PubMed ID: 29237157
[TBL] [Abstract][Full Text] [Related]
11. HNRNPAB induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by transcriptionally activating SNAIL.
Zhou ZJ; Dai Z; Zhou SL; Hu ZQ; Chen Q; Zhao YM; Shi YH; Gao Q; Wu WZ; Qiu SJ; Zhou J; Fan J
Cancer Res; 2014 May; 74(10):2750-62. PubMed ID: 24638979
[TBL] [Abstract][Full Text] [Related]
12. Apigenin inhibits NF-κB and snail signaling, EMT and metastasis in human hepatocellular carcinoma.
Qin Y; Zhao D; Zhou HG; Wang XH; Zhong WL; Chen S; Gu WG; Wang W; Zhang CH; Liu YR; Liu HJ; Zhang Q; Guo YQ; Sun T; Yang C
Oncotarget; 2016 Jul; 7(27):41421-41431. PubMed ID: 27203387
[TBL] [Abstract][Full Text] [Related]
13. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA-22/Snail family transcriptional repressor 1 axis.
Chen S; Wang G; Tao K; Cai K; Wu K; Ye L; Bai J; Yin Y; Wang J; Shuai X; Gao J; Pu J; Li H
Cancer Sci; 2020 May; 111(5):1582-1595. PubMed ID: 32129914
[TBL] [Abstract][Full Text] [Related]
15. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Zhou W; Gong L; Wu Q; Xing C; Wei B; Chen T; Zhou Y; Yin S; Jiang B; Xie H; Zhou L; Zheng S
J Exp Clin Cancer Res; 2018 Sep; 37(1):215. PubMed ID: 30180906
[TBL] [Abstract][Full Text] [Related]
16. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression.
Dong Y; Sun X; Zhang K; He X; Zhang Q; Song H; Xu M; Lu H; Ren R
Bioengineered; 2021 Dec; 12(2):12967-12979. PubMed ID: 34939898
[TBL] [Abstract][Full Text] [Related]
17. Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway.
Wang J; Zhang N; Han Q; Lu W; Wang L; Yang D; Zheng M; Zhang Z; Liu H; Lee TH; Zhou XZ; Lu KP
Cancer Lett; 2019 Mar; 444():82-93. PubMed ID: 30583078
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma.
Zhang L; Huang G; Li X; Zhang Y; Jiang Y; Shen J; Liu J; Wang Q; Zhu J; Feng X; Dong J; Qian C
BMC Cancer; 2013 Mar; 13():108. PubMed ID: 23496980
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC
Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482
[TBL] [Abstract][Full Text] [Related]
20. FOXF2 deficiency promotes hepatocellular carcinoma metastasis by inducing mesenchymal-epithelial transition.
Dou C; Jin X; Sun L; Zhang B; Han M; Li T
Cancer Biomark; 2017 Jul; 19(4):447-454. PubMed ID: 28582850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]